546 A phase I dose escalation study of STEMVAC, a multi-antigen, multi-epitope Th1 selective plasmid-based vaccine, targeting stem cell associated proteins in patients with advanced breast cancer
Regular and Young Investigator Award Abstracts（2022）
关键词
breast cancer,stemvac cell,vaccine,multi-antigen,multi-epitope,plasmid-based
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要